BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20006567)

  • 1. Metalloporphyrins in the management of neonatal hyperbilirubinemia.
    Stevenson DK; Wong RJ
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):164-8. PubMed ID: 20006567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tin-metalloporphyrins: an answer to neonatal jaundice?
    Steffensrud S
    Neonatal Netw; 1998 Aug; 17(5):11-7; quiz 18-9. PubMed ID: 9791442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.
    Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A
    Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of severe neonatal hyperbilirubinemia.
    Drummond GS; Kappas A
    Semin Perinatol; 2004 Oct; 28(5):365-8. PubMed ID: 15686268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
    Suresh GK; Martin CL; Soll RF
    Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.
    Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T
    J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
    Valaes T; Drummond GS; Kappas A
    Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of light on metalloporphyrin-treated newborn mice.
    Wong RJ; Schulz S; Espadas C; Vreman HJ; Rajadas J; Stevenson DK
    Acta Paediatr; 2014 May; 103(5):474-9. PubMed ID: 24417721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin.
    Kappas A
    Pediatrics; 2004 Jan; 113(1 Pt 1):119-23. PubMed ID: 14702459
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.
    Martinez JC; Garcia HO; Otheguy LE; Drummond GS; Kappas A
    Pediatrics; 1999 Jan; 103(1):1-5. PubMed ID: 9917431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin.
    Alexander D
    Pediatrics; 2004 Jan; 113(1 Pt 1):135. PubMed ID: 14702465
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of zinc deuteroporphyrin bis glycol on newborn mice after heme loading.
    He CX; Campbell CM; Zhao H; Kalish FS; Schulz S; Vreman HJ; Wong RJ; Stevenson DK
    Pediatr Res; 2011 Nov; 70(5):467-72. PubMed ID: 21785387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns.
    Kappas A; Drummond GS; Henschke C; Valaes T
    Pediatrics; 1995 Apr; 95(4):468-74. PubMed ID: 7700742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase- deficient newborns.
    Kaplan M; Hammerman C
    Pediatrics; 1999 Feb; 103(2):536-7. PubMed ID: 10026070
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.
    Bhutani VK; Poland R; Meloy LD; Hegyi T; Fanaroff AA; Maisels MJ
    J Perinatol; 2016 Jul; 36(7):533-9. PubMed ID: 26938918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin.
    Drummond GS; Kappas A
    J Clin Invest; 1984 Jul; 74(1):142-9. PubMed ID: 6547455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative metalloporphyrins for the treatment of neonatal jaundice.
    Vreman HJ; Wong RJ; Stevenson DK
    J Perinatol; 2001 Dec; 21 Suppl 1():S108-13; discussion S125-7. PubMed ID: 11803430
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of light exposure on metalloporphyrin-treated newborn mice.
    Schulz S; Wong RJ; Kalish FS; Zhao H; Jang KY; Vreman HJ; Stevenson DK
    Pediatr Res; 2012 Aug; 72(2):161-8. PubMed ID: 22580722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production.
    Simionatto CS; Anderson KE; Drummond GS; Kappas A
    J Clin Invest; 1985 Feb; 75(2):513-21. PubMed ID: 3838318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.